Related Experiment Video

Updated: Aug 3, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Chlamydia pneumoniae pneumonia

T M File1, J S Tan

  • 1Northeastern Ohio Universities College of Medicine, Rootstown, Ohio, USA.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed

Insights

Chlamydia pneumoniae causes community-acquired pneumonia, lacking a rapid diagnostic standard. Definitive diagnosis involves antibody titers, PCR, or culture, with treatment including macrolides, tetracyclines, or fluoroquinolones.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Respiratory Medicine

Background:

  • Chlamydia pneumoniae is a frequent pathogen causing community-acquired pneumonia.
  • Current diagnostic methods lack a definitive "gold standard" and rapid testing is unavailable.
  • Clinical presentation varies based on infection type, co-infections, and patient health.

Purpose of the Study:

  • To review the diagnostic challenges and therapeutic recommendations for Chlamydia pneumoniae pneumonia.
  • To highlight the variability in clinical manifestations and severity.

Main Methods:

  • Literature review of diagnostic approaches for Chlamydia pneumoniae.
  • Analysis of clinical features and treatment guidelines.
  • Evaluation of serological and molecular diagnostic markers.

Main Results:

  • A fourfold rise in antibody titer, alongside positive PCR or culture, indicates acute infection.
  • Chlamydia pneumoniae can cause both non-severe and severe pneumonia requiring ICU admission.
  • Treatment options include macrolides, tetracyclines, and fluoroquinolones.

Conclusions:

  • Accurate and rapid diagnosis of Chlamydia pneumoniae pneumonia remains a challenge.
  • Understanding varied clinical presentations is crucial for effective management.
  • Established therapeutic regimens are available for treating Chlamydia pneumoniae infections.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...